Invasive group A streptococcal infection in children: Clinical manifestations and molecular characterization in a French pediatric tertiary care center

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 3, 2010, Pages 341-346

  Henriet, S ^a   Kaguelidou, F ^a,b,c   Bidet, P ^a,b   Lorrot, M ^a,b   De Lauzanne, A ^a   Dauger, S ^a,b   Angoulvant, F ^a   Mercier, J C ^a,b   Alberti, C ^a,b,c   Bingen, E ^a,b   Faye, A ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; FOSFOMYCIN; PENICILLIN G; VANCOMYCIN; VIRULENCE FACTOR;

ADOLESCENT; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BONE INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; FRANCE; GENOTYPE; GROUP A STREPTOCOCCAL INFECTION; HOSPITAL ADMISSION; HUMAN; INFANT; MALE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BONE DISEASES, INFECTIOUS; CARRIER PROTEINS; CHILD, PRESCHOOL; COHORT STUDIES; EXOTOXINS; FEMALE; FRANCE; HUMANS; MALE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

EID: 77952421046     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0854-x     Document Type: Article

References (23)

1. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470-511
2. Cimolai N, Trombley C, Adderley RJ, Tredwell SJ (1992) Invasive Streptococcus pyogenes infections in children. Can J Public Health 83(3):230-233
3. Davies HD, Matlow A, Scriver SR, Schlievert P, Lovgren M, Talbot JA et al (1994) Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 13(1):49-56
4. Mulla ZD (2007) Clinical and epidemiologic features of invasive group A streptococcal infections in children. Pediatr Int 49(3):355-358
5. Beall B, Facklam R, Thompson T (1996) Sequencing emmspecific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953-958
6. Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC et al (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188(10):1578-1586
7. Bidet P, Courroux C, Salgueiro C, Carol A, Mariani-Kurkdjian P, Bonacorsi S et al (2007) Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children. J Clin Microbiol 45(6):2002-2004
8. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C et al (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45(4):450-458
9. Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M et al (2006) Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 55(Pt 8):1115-1123
10. Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P (2009) Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J 28(6):541-543
11. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46 (7):2359-2367
12. Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA (2001) Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 107(5):1108-1115
13. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A et al (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 45(7):853-862
14. Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T et al (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11(7):1062-1066
15. Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 10(9):179-184
16. Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14(1):2-11
17. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM et al (2002) Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 35(3):268-276
18. Vlaminckx BJ, van PeltW, Schouls LM, van SilfhoutA,Mascini EM, Elzenaar CP et al (2005) Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003. Clin Microbiol Infect 11(3):226-231
19. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A et al (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47(4):1155-1165
20. Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC et al (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41(11):4941-4949
21. McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ et al (2006) Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis 43(7):884-891
22. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL et al (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis 41(5):599-608
23. Tanz RR, Shulman ST, Shortridge VD, Kabat W, Kabat K, Cederlund E et al (2004) Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis 39(12):1794-1801